糖尿病视网膜病变炎症的研究新进展

被引:50
作者
兰文
陆燕
王春红
胡钦瑞
黄振平
机构
[1] 南京大学医学院临床学院,南京军区南京总医院眼科
关键词
糖尿病视网膜病变; 炎症; 细胞因子;
D O I
10.13389/j.cnki.rao.2013.02.026
中图分类号
R774.1 [视网膜疾病];
学科分类号
100212 [眼科学];
摘要
糖尿病视网膜病变是糖尿病最严重的微血管慢性并发症之一,其发病机制复杂,至今尚未完全阐明。新的研究发现视网膜炎症在糖尿病视网膜病变的发病机制中起重要作用。一些常见的炎症因子在糖尿病视网膜病变的血清、玻璃体、房水中含量增加,它们之间的相互作用影响了疾病的发生发展。本文就炎症在糖尿病视网膜病变中作用的研究新进展作一综述,分析更多的分子机制以寻找可能的治疗靶点。
引用
收藏
页码:197 / 200
页数:4
相关论文
共 7 条
[1]
Serum inflammatory cytokines IL-1β; IL-6; TNF-α and VEGF have influence on the development of diabetic retinopathy.[J].Desislava N. Koleva-Georgieva;Nelly P. Sivkova;Dora Terzieva.Folia Medica.2011, 2
[2]
Candesartan Attenuates Diabetic Retinal Vascular Pathology by Restoring Glyoxalase-I Function [J].
Miller, Antonia G. ;
Tan, Genevieve ;
Binger, Katrina J. ;
Pickering, Raelene J. ;
Thomas, Merlin C. ;
Nagaraj, Ram H. ;
Cooper, Mark E. ;
Wilkinson-Berka, Jennifer L. .
DIABETES, 2010, 59 (12) :3208-3215
[3]
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment [J].
Kessenbrock, Kai ;
Plaks, Vicki ;
Werb, Zena .
CELL, 2010, 141 (01) :52-67
[4]
Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism as a potential risk factor for diabetic retinopathy in Japanese patients with type 2 diabetes.[J].Naoto Katakami;Munehide Matsuhisa;Hideaki Kaneto;Taka-aki Matsuoka;Kenichi Imamura;Fukashi Ishibashi;Tsutomu Kanda;Koichi Kawai;Takeshi Osonoi;Atsunori Kashiwagi;Ryuzo Kawamori;Iichiro Shimomura;Yoshimitsu Yamasaki.Diabetes Research and Clinical Practice.2010, 1
[5]
Identification of a Retinal Aldosterone System and the Protective Effects of Mineralocorticoid Receptor Antagonism on Retinal Vascular Pathology [J].
Berka, Jennifer L. Wilkinson ;
Tan, Genevieve ;
Jaworski, Kassie ;
Miller, Antonia G. .
CIRCULATION RESEARCH, 2009, 104 (01) :124-U309
[6]
Medication use and disease management of type 2 diabetic flemish patients [J].
Els Mehuys ;
Leen De Bolle ;
Luc Van Bortel ;
Lieven Annemans ;
Inge Van Tongelen ;
Jean-Paul Remon ;
Mimi Giri .
Pharmacy World & Science, 2008, 30 :51-56
[7]
Aqueous levels of macrophage migration inhibitory factor and monocyte chemotactic protein-1 in patients with diabetic retinopathy [J].
Tashimo, A ;
Mitamura, Y ;
Nagai, S ;
Nakamura, Y ;
Ohtsuka, K ;
Mizue, Y ;
Nishihira, J .
DIABETIC MEDICINE, 2004, 21 (12) :1292-1297